(Q52925796)
Statements
Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective. (English)
D K Heyland
A Gafni
M A Levine
1 September 2000
53
9
888-894